Back to Search Start Over

Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Authors :
Theurillat JP
Udeshi ND
Errington WJ
Svinkina T
Baca SC
Pop M
Wild PJ
Blattner M
Groner AC
Rubin MA
Moch H
Prive GG
Carr SA
Garraway LA
Source :
Science (New York, N.Y.) [Science] 2014 Oct 03; Vol. 346 (6205), pp. 85-89. Date of Electronic Publication: 2014 Oct 02.
Publication Year :
2014

Abstract

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.<br /> (Copyright © 2014, American Association for the Advancement of Science.)

Details

Language :
English
ISSN :
1095-9203
Volume :
346
Issue :
6205
Database :
MEDLINE
Journal :
Science (New York, N.Y.)
Publication Type :
Academic Journal
Accession number :
25278611
Full Text :
https://doi.org/10.1126/science.1250255